About Sentrx
Sentrx is a company based in Little Falls (United States) founded in 1995 was acquired by C3i Solutions in April 2013. Sentrx operates in a competitive market with competitors including DrugCard, biologit, Beijing Dongxie Network, Advera Health and My Meds & Me, among others.
- Headquarter Little Falls, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$3 M (USD), Debt – Conventional
Feb 04, 2009
-
Investors
C3i Solutions
& 3 more
-
Employee Count
Employee Count
-
Acquired by
C3i Solutions
(Apr 08, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sentrx
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $3.0M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2009 | Amount | Debt – Conventional - Sentrx | Valuation |
investors |
|
| Jun, 2006 | Amount | Unspecified - Sentrx | Valuation | Argosy Capital |
Investors in Sentrx
Sentrx has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include C3i Solutions, MMV Financial and Argosy Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
|
Founded Year | Domain | Location | |
|
Argosy Capital is focused on investment management across multiple sectors.
|
Founded Year | Domain | Location | |
|
Provider of a growth equity firm for adaptive and personalized plans
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sentrx
Financial Statements - Sentrx
Sentrx Comparisons
Competitors of Sentrx
Sentrx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DrugCard, biologit, Beijing Dongxie Network, Advera Health and My Meds & Me, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug pharmacovigilance solutions are provided for pharmaceutical industries.
|
|
| domain | founded_year | HQ Location |
AI-based solutions for drug pharmacovigilance are provided.
|
|
| domain | founded_year | HQ Location |
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
|
|
| domain | founded_year | HQ Location |
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
|
| domain | founded_year | HQ Location |
Adverse events and product quality are captured for life sciences.
|
Frequently Asked Questions about Sentrx
Sentrx was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Sentrx is headquartered in Little Falls, United States. It is registered at Little Falls, Minnesota, United States.
Sentrx, (acquired by Telerx in 2013) is a developer and provider of drug safety software solutions and hosting services for the Oracle Argus Safety Suite.The company offers solutions to biopharma organizations for improving safety, adverse event and medical affairs management. Their services range from adverse event data collection and management to safety system setup and hosting and also include primary and secondary research, trend analysis etc. Their proprietary clinical safety solutions include SaPh (a drug safety database management solution with tools and services to manage safety systems), CROPlus (a channel partner solution, offering flexible pharmacovigilance reporting packages) and UniPhi (a single source solution, which integrates all core Sentrx transactions and technology capabilities) which are integrated, customizable and scalable.
Sentrx's top competitors include biologit, My Meds & Me and DrugCard.
Sentrx has 4 investors. Key investors include C3i Solutions, MMV Financial, Argosy Capital, and Edison Partners.